Dr Amit Sengupta, a treatment activist who dedicated his life to universal access, dies age 60
We are deeply saddened by the loss of Dr Amit Sengupta, our friend, colleague, and an inspiring treatment activist who...
Read more about Dr Amit Sengupta, a treatment activist who dedicated his life to universal access, dies age 60
African civil society plans for regional collaboration in tackling intellectual property barriers
First published by KELIN. ‘This meeting gives me hope that we can build a solid movement across Eastern and Southern...
Read more about African civil society plans for regional collaboration in tackling intellectual property barriers
FAQs for women of childbearing potential and dolutegravir: Key interim considerations
A forum on the risks of preconception dolutegravir exposure has pulled together frequently asked questions (FAQs) designed to help provide...
Read more about FAQs for women of childbearing potential and dolutegravir: Key interim considerations
“HIV treatment is not sustainable, you must involve civil society to increase access,” treatment activists in Latin America and the Caribbean tell ViiV Healthcare.
Treatment activists, representing 13 countries in the Latin America and Caribbean region (LACTA), met with ViiV Healthcare in Panama City...
Read more about “HIV treatment is not sustainable, you must involve civil society to increase access,” treatment activists in Latin America and the Caribbean tell ViiV Healthcare.
2018 applications open! Online course on reducing barriers to essential medicines in Africa
Applications are open now for this year’s intellectual property (IP) and access to medicines online course. The course is led...
Read more about 2018 applications open! Online course on reducing barriers to essential medicines in Africa
Activists fear looming health crisis in Argentina – call on IMF to act
Today global health activists took to the streets in Washington DC to highlight the looming health crisis facing the people...
Read more about Activists fear looming health crisis in Argentina – call on IMF to act
Unitaid investment expands our work on access to medicines
ITPC is delighted to be named one of three successful grantees of a new three year investment from Unitaid to...
Read more about Unitaid investment expands our work on access to medicines
Argentina’s drastic austerity measures puts lives at stake
This week (3 Aug 2018) Argentina’s President, Mauricio Macri, announced sweeping austerity measures. These cuts include slashing the budget for...
Read more about Argentina’s drastic austerity measures puts lives at stake
The people against Gilead. Activists protest at the Brazilian patent office, calling for Gilead’s last sofosbuvir patent application to be rejected
Activists gathered at the Brazilian Patent Office (INPI) in Rio de Janeiro this week, and Gilead’s office in São Paulo....
Read more about The people against Gilead. Activists protest at the Brazilian patent office, calling for Gilead’s last sofosbuvir patent application to be rejected
Overpatented, overpriced: How excessive pharmaceutical patenting is extending monopolies and driving up drug prices
This new report by our partner I-MAK analyzes the twelve best selling drugs in the United States and shows how...
Read more about Overpatented, overpriced: How excessive pharmaceutical patenting is extending monopolies and driving up drug prices